PNT — POINT Biopharma Global Share News
0.000.00%
Last trade - 00:00HealthcareSpeculativeMid Cap
- $1.33bn
- $998.03m
- $226.58m
Point Biopharma Global Inc Expected To Post A Loss Of 28 Cents A Share: Earnings Preview
Brief: Point Biopharma Publishes Preclinical Data For Actinium-Labelled Pnt2001
Oppenheimer bullish on Point Biopharma's radiopharmaceutical therapies
U.S. RESEARCH ROUNDUP-Adobe, Benefitfocus, Fedex
U.S. STOCKS ON THE MOVE-Nucor, Larimar Therapeutics, gold miners
U.S. STOCKS ON THE MOVE-Johnson & Johnson, Altimmune, Twilio
U.S. STOCKS ON THE MOVE-Crypto stocks, AVROBIO, Scisparc
U.S. STOCKS ON THE MOVE-Starbucks, J&J, Nikola, Conformis, PayPal
Point Biopharma drops on discounted stock offering
Brief: Point Biopharma Prices Public Offering Of 13.9 Million Common Shares At $9.00 per Share
Brief: Point Biopharma Announces Proposed Public Offering Of Common Stock
Point Biopharma Jumps On Late: stage data from prostate cancer drug trial
U.S. RESEARCH ROUNDUP- Booking Holdings, Carvana, Kroger
Brief: Point Biopharma Provides Updated Efficacy And Safety Data From The Lead-In Cohort Of The Phase 3 Splash Trial In MCRPC
U.S. STOCKS ON THE MOVE-Pinterest, Aemetis, Walmart
U.S. STOCKS ON THE MOVE-Twitter, ChargePoint, IMAX
JonesTrading starts coverage of Point Biopharma with 'buy' on pipeline strength
U.S. RESEARCH ROUNDUP-Golden Entertainment, Red Rock Resorts, Signify Health
Brief: POINT Biopharma To Publish Abstract At ESMO Congress 2022